Export

EN
FR
Tirzepatide
Essential medicine status
General description

Medicine type
Biological agent
EML status history
Application rejected in 2025 (TRS 1064) for Obesity
Changed in 2025 (TRS 1064) for Type 2 diabetes mellitus
Therapeutic equivalent for
semaglutide for Obesity, unspecified
semaglutide for Type 2 diabetes mellitus
Wikipedia
Tirzepatide
DrugBank
Tirzepatide